Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier.

Literature DB >> 26403715

Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier.

Leonardo M Del Grande¹, Fernando A M Herbella², Amilcar M Bigatao³, Henrique Abrao¹, Jose R Jardim³, Marco G Patti⁴.

Abstract

Entities: Disease Species

Keywords: Chronic obstructive pulmonary disease; Esophageal pH monitoring; Gastroesophageal reflux; High-resolution esophageal manometry

Year: 2015 PMID： 26403715 DOI： 10.1007/s11605-015-2955-4

Source DB: PubMed Journal: J Gastrointest Surg ISSN： 1091-255X Impact factor: 3.452

× No keyword cloud information.

30 in total

Review 1. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease.

Authors: Sundeep Salvi
Journal: Clin Chest Med Date: 2013-12-12 Impact factor: 2.878

2. Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.

Authors: Marco E Allaix; Piero M Fisichella; Imre Noth; Fernando A Herbella; Bernardo Borraez Segura; Marco G Patti
Journal: J Gastrointest Surg Date: 2013-09-04 Impact factor: 3.452

3. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy.

Authors: C A Pellegrini; T R DeMeester; L F Johnson; D B Skinner
Journal: Surgery Date: 1979-07 Impact factor: 3.982

4. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors: Anne Lindberg; A Bjerg; Anders Bjerg-Bäcklund; Eva Rönmark; Lars-Gunnar Larsson; Bo Lundbäck
Journal: Respir Med Date: 2005-06-21 Impact factor: 3.415

5. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors: B Lundbäck; A Lindberg; M Lindström; E Rönmark; A C Jonsson; E Jönsson; L G Larsson; S Andersson; T Sandström; K Larsson
Journal: Respir Med Date: 2003-02 Impact factor: 3.415

6. Idiopathic pulmonary fibrosis: how often is it really idiopathic?

Authors: Marco G Patti; Pietro Tedesco; Jeffrey Golden; Steven Hays; Charles Hoopes; Adam Meneghetti; Tanuja Damani; Lawrence W Way
Journal: J Gastrointest Surg Date: 2005-11 Impact factor: 3.452

Review 7. Gastroesophageal reflux disease: From pathophysiology to treatment.

Authors: Fernando A Herbella; Marco G Patti
Journal: World J Gastroenterol Date: 2010-08-14 Impact factor: 5.742

8. Preoperative lower esophageal sphincter manometry data neither impact manifestations of GERD nor outcome after laparoscopic Nissen fundoplication.

Authors: Otto Riedl; Michael Gadenstätter; Wolfgang Lechner; Gerhard Schwab; Martina Marker; Ruxandra Ciovica
Journal: J Gastrointest Surg Date: 2009-04-16 Impact factor: 3.452

Review 9. Recent clinical investigations examining the association of asthma and gastroesophageal reflux.

Authors: Susan M Harding
Journal: Am J Med Date: 2003-08-18 Impact factor: 4.965

10. Ratio between proximal/distal gastroesophageal reflux does not discriminate abnormal proximal reflux.

Authors: Sebastião Carlos Pannocchia Neto; Fernando A M Herbella; Luciana C Silva; Marco G Patti
Journal: World J Surg Date: 2014-04 Impact factor: 3.352

10 in total

1. Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (GERD).

Authors: Leonardo M Del Grande; Fernando A M Herbella; Amilcar M Bigatao; Jose R Jardim; Marco G Patti
Journal: J Gastrointest Surg Date: 2016-06-27 Impact factor: 3.452

Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier.

Review 1. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease.

2. Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.

3. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy.

4. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.

5. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

6. Idiopathic pulmonary fibrosis: how often is it really idiopathic?

Review 7. Gastroesophageal reflux disease: From pathophysiology to treatment.

8. Preoperative lower esophageal sphincter manometry data neither impact manifestations of GERD nor outcome after laparoscopic Nissen fundoplication.

Review 9. Recent clinical investigations examining the association of asthma and gastroesophageal reflux.

10. Ratio between proximal/distal gastroesophageal reflux does not discriminate abnormal proximal reflux.

1. Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (GERD).

Review 2. Pathophysiology of gastroesophageal reflux disease: how an antireflux procedure works (or does not work).

Review 3. Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies.

4. Minor psychiatric disorders and objective diagnosis of gastroesophageal reflux disease.

Review 5. Pathophysiology of Gastroesophageal Reflux Disease.

Review 6. The upper esophageal sphincter in the high-resolution manometry era.

7. Proton pump inhibitors for chronic obstructive pulmonary disease.

8. Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications.

Review 9. Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.

Review 10. Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.